|
Volumn 21, Issue 4, 2003, Pages 299-303
|
When should vaccine be used in cholera-endemic areas?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLERA VACCINE;
INACTIVATED VACCINE;
CHOLERA;
COMPUTER MODEL;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
EDITORIAL;
ENDEMIC DISEASE;
ENVIRONMENTAL SANITATION;
EPIDEMIOLOGICAL DATA;
HEALTH CARE COST;
HEALTH CARE FACILITY;
HEALTH CARE FINANCING;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HEALTH PROGRAM;
HEALTH SURVEY;
HIGH RISK POPULATION;
HOSPITAL COST;
HUMAN;
MEDICAL DECISION MAKING;
MEDICAL DOCUMENTATION;
PUBLIC HEALTH SERVICE;
REFUGEE;
SYMPTOMATOLOGY;
WORLD HEALTH ORGANIZATION;
COST BENEFIT ANALYSIS;
ECONOMICS;
MASS IMMUNIZATION;
NOTE;
ORAL DRUG ADMINISTRATION;
PREVALENCE;
SAFETY;
UTILIZATION REVIEW;
ADMINISTRATION, ORAL;
CHOLERA;
CHOLERA VACCINES;
COST-BENEFIT ANALYSIS;
ENDEMIC DISEASES;
HUMANS;
MASS IMMUNIZATION;
PREVALENCE;
SAFETY;
VACCINES, INACTIVATED;
WORLD HEALTH ORGANIZATION;
|
EID: 1542620676
PISSN: 16060997
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (16)
|
References (9)
|